| 期刊論文1. | Hahl, J.、Hamalainen, H.、Sintonen, H.、Simell, T.、Arinen, S.、Simell, O.(2002)。Health-related quality of life in type 1 diabetes without or with symptoms of long-term complications。Quality of Life Research,11,427-436。 | 2. | Saito, I.、Inami, F.、Ikebe, T.、Moriwaki, C.、Tsubakimoto, A.、Yonemasu, K.(2006)。Impact of diabetes on health-related quality of life in a population study in Japan。Diabetes Research & Clinical Practice,73,51-57。 | 3. | Chobanian, A. V.、Bakris, G. L.、Black, H. R.、Cushman, W. C.、Green, L. A.、Izzo, J. J.、Oparil, S.(2003)。The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure。JAMA,289(19),2560-2572。 | 4. | Hanley, J. A.、McNeil, B. J.(1982)。The meaning and use of the area under a receiver operating characteristic (ROC) curve。Radiology,143(1),29-36。 | 5. | American Diabetes Association.(2007)。Standards of Medical Care in Diabetes-2007。Diabetes Care,30(Supple 1),S4-S41。 | 6. | National Kidney Foundation(2002)。K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification。American Journal of Kidney Diseases,39(2),1-266。 | 7. | Jacobson, A. M.、de Groot, M.、Samson, J. A.(1994)。The Evaluation of Two Measures of Quality of Life in Patients with Type I and Type II Diabetes。Diabetes Care,17(4),267-274。 | 8. | Gill, T. M.、Feinstein, A. R.(1994)。A Critical Appraisal of the Quality of Quality-of-life Measurements。JAMA: The Journal of the American Medical Association,272(8),619-626。 | 9. | 曾旭民、盧瑞芬、蔡益堅(20031200)。國人生活品質評量(Ⅱ):SF-36臺灣版的常模與效度檢測。臺灣公共衛生雜誌,22(6),512-518。 延伸查詢 | 10. | Revicki DA, Osoba D, Fairclough D, etal.(2000)。Recommendations on health-related quality of life to support labeling and promotional claims in the United States。Qual Life Res,9,887-900。 | 11. | de Vet HC, Ader HJ, Terwee CB, Pouwer F.(2005)。Are factor analytical techniques used appropriately in the validation of health status questionnaires? A systematic review on the quality of factor analysis of the SF-36。Qual Life Res,14,1203-24。 | 12. | Glasgow RE, Ruggiero L, Eakin EG, Dryfoos J, Chobanian L.(1997)。Quality of life and associated characteristics in a large national sample of adults with diabetes。Diabetes Care,20,562-7。 | 13. | Hanley JA, McNeil BJ.(1983)。A method of comparing the areas under receiver operating characteristic curves derived from the same cases。Radiology,148,839-43。 | 14. | Arauz-Pacheco C, Parrott MA, Raskin P, American Diabetes Association.(2003)。Treatment of hypertension in adults with diabetes。Diabetes Care,26(suppl 1),S80-582。 | 15. | Testa MA, Simonson DC.(1998)。Health economic benefits and quality of life during improved glycemic control in patients with type 2 diabetes mellitus: a randomized, controlled, double-blind trial。JAMA,280,1490-6。 | 16. | Testa MA, Simonson DC, Turner RR.(1998)。Valuing quality of life and improvements in glycemic control in people with type 2 diabetes。Diabetes Care,21(Suppl 3),C44-52。 | 17. | Wikblad K, Leksell J, Wibell L.(1996)。Health-related quality of life in relation to metabolic control and late complications in patients with insulin dependent diabetes mellitus。Qual Life Res,5,123-30。 | 18. | UK Prospective Diabetes Study Group.(1999)。Quality of life in type 2 diabetic patients is affected by complications but not by intensive policies to improve blood glucose or blood pressure control (UKPDS 37)。Diabetes Care,22,1125-36。 | 19. | Anderson RM, Fitzgerald JT, Wisdom K, Davis WK, Hiss RG.(1997)。A comparison of global versus diseasespecific quality-of-life measures in patients with0 NIDDM。Diabetes Care,20,299-305。 | 20. | Wei JN, Chuang LM, Lin RS, Chao CL, Sung FC.(2000)。Prevalence and hospitalization rates of diabetes mellitus in Taiwan。J Public Health,21,173-80。 | 21. | World Health Organization Quality of Life Group.(1982)。The World Health Organization Quality of Life assessment (WHOQOL): position paper from the World Health Organization, 1995b。Soc Sci Med,41,1403-9。 | 22. | Berzon R, Hays RD, Shumaker SA.(1993)。International use, application and performance of health-related quality of life instruments。Qual Life Res,2,367-8。 | 23. | Naughton MJ, Shumaker SA.(2003)。The case for domains of function in quality of life assessment。Qual Life Res,12(Suppl 1),73-80。 | 24. | Garratt AM, Schmidt L, Fitzpatrick R.(2002)。Patient assessed health outcome measures for diabetes: a structured review。Diabet Med,19,1-11。 | 25. | Watkins K, Connell CM.(2004)。Measurement of healthrelated QOL in diabetes mellitus。Pharmacoeconomics,22,1109-26。 | 26. | Huang MC, Hung CH.(2007)。Quality of life and its predictors for middle-aged and elderly patients with type 2 diabetes mellitus。J Nurs Res,15,193-201。 | 27. | Li TC, Lee YD, Lin CC, Amidon RL.(2004)。Quality of life of primary caregivers of elderly with cerebrovascular disease or diabetes hospitalized for acute care: assessment of well-being and functioning using the SF-36 health questionnaire。Qual Life Res,13,1081-8。 | 28. | Li TC, Lin CC, Liu CS, Li CI, Lee YD.(2006)。Validation of the Chinese version of the diabetes impact measurement scales amongst people suffering from diabetes。Qual Life Res,15,1613-9。 | 29. | Boyer JG, Earp JA.(1997)。The development of an instrument for assessing the quality of life of people with diabetes. Diabetes-39。Med Care,35,440-53。 | 30. | Wild D, Grove A, Martin M, et al.(2005)。Principles of Good Practice for the Translation and Cultural Adaptation Process for Patient-Reported Outcomes (PRO) Measures: report of the ISPOR Task Force for Translation and Cultural Adaptation。Value Health,8,94-104。 | 31. | Goddijn P, Bilo H, Meadows K, Groenier K, Feskens E, Meyboom-de Jong B.(1996)。The validity and reliability of the Diabetes Health Profile (DHP) in NIDDM patients referred for insulin therapy。Qual Life Res,5,433-42。 | 32. | Maddigan SL, Feeny DH, Johnson JA, DOVE Investigators.(2004)。Construct validity of the RAND-12 and Health Utilities Index Mark 2 and 3 in type 2 diabetes。Qual Life Res,13,435-48。 | 33. | Bonora E, Muggeo M.(2001)。Postprandial blood glucose as a risk factor for cardiovascular disease in Type II diabetes: the epidemiological evidence。Diabetologia,44,2107-14。 | 34. | Ceriello A.(2005)。Postprandial hyperglycemia and diabetes complications: is it time to treat?。Diabetes,54,1-7。 | 35. | Gerich, J. E.(2003)。Clinical significance, pathogenesis, and management of postprandial hyperglycemia。Archives of Internal Medicine,163,1306-1316。 | 36. | The Diabetes Control and Complications Trial.(1995)。The relationship of glycemic exposure (HbA1c) to the risk of development and progression of retinopathy in the diabetes control and complications trial。Diabetes,44,968-83。 | 37. | Cavalit F, Petrelli A, Traversa M, et al.(2006)。Postprandial blood glucose is a stronger predictor of cardiovascular events than fast blood glucose in type 2 diabetes mellitus, particularly in women: lesions from the San Luigi Gonzaga Diabetes Study。J Clin Endocrinol Metab,91,813-9。 | 38. | Lloyd CE, Mattews KA, Wing RR, Orchard TJ.(1992)。Psychosocial factors and complications of IDDM. The Pittsburgh Epidemiology of Diabetes Complications Study. VIII。Diabetes Care,15,166-72。 | 39. | Rijken M, van Kerkhof M, Dekker J, Schellevis FG.(2005)。Comorbidity of chronic diseases: effects of disease pairs on physical and mental functioning。Qual Life Res,14,45-55。 | 40. | Johnson JA, Maddigan SL.(2004)。Performance of the RAND-12 and SF-12 summary scores in type 2 diabetes。Qual Life Res,13,449-56。 | 41. | Crosby RD, Kolotkin RL, Williams GR.(2003)。Defining clinically meaningful change in health-related quality of life。J Clin Epidemiol,56,395-407。 | 圖書1. | Nunnally, Jum C.、Bernstein, Ira H.(1994)。Psychological theory。MacGraw-Hill。 | 2. | Kasper DL, Braunwald E, Hauser S, et al.(2004)。Harrison’s Principles of Internal Medicine。New York。 | |
| |